NIA
CRL icon

Northstar Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Northstar Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3.72M Sell
9,147
-226
-2% -$75.5K 0.49% 60
2021
Q1 		$2.72M Buy
9,373
+3,026
+48% +$841K 0.4% 69
2020
Q4 		$1.59M Buy
+6,347
New +$1.51M 0.25% 80

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northstar Investment Advisors's CRL Position: Q2 2021 in Review

Northstar Investment Advisors reduced its Charles River Laboratories (CRL) stake by 2.4% in Q2 2021, selling an estimated $75.5K and leaving 9,147 shares worth $3.72M. The position accounts for 0.49% of the portfolio, ranked #60.

Northstar Investment Advisors first reported a position in CRL in Q4 2020 and has held it in 3 quarters since. 638 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

  • Northstar Investment Advisors held 9,147 shares of Charles River Laboratories worth $3.72M as of Q2 2021.
  • Northstar Investment Advisors sold 226 Charles River Laboratories shares in Q2 2021, an estimated $75.5K.
  • Charles River Laboratories made up 0.49% of Northstar Investment Advisors's portfolio in Q2 2021, its #60 holding.
  • Northstar Investment Advisors first reported a position in Charles River Laboratories in Q4 2020 and has held it in 3 quarters since.
  • 638 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Northstar Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.